Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
ActivB12 100microgram tablets
0901020D0BQADAJ
|
ActivB12 | Cyanocobalamin | Nutrition and Blood | 1 |
|
Cytamen 1000micrograms/1ml solution for injection ampoules
0901020D0BBABAD
|
Cytamen | Cyanocobalamin | Nutrition and Blood | 1 |
|
SunVit-Pro Vitamin B12 100microgram tablets
0901020D0BPACAJ
|
SunVit-Pro Vitamin B12 | Cyanocobalamin | Nutrition and Blood | 1 |
|
ActivB12 1mg modified-release tablets
0901020D0BQABAH
|
ActivB12 | Cyanocobalamin | Nutrition and Blood | No data available |
|
ActivB12 1mg tablets
0901020D0BQAAAF
|
ActivB12 | Cyanocobalamin | Nutrition and Blood | No data available |
|
ActivB12 50microgram tablets
0901020D0BQACAE
|
ActivB12 | Cyanocobalamin | Nutrition and Blood | No data available |
|
Behepan 1mg tablets
0901020D0BDAAAF
|
Behepan | Cyanocobalamin | Nutrition and Blood | No data available |
|
Cyanocobalamin 35micrograms/5ml oral solution
0901020D0AAAGAG
|
Cyanocobalamin | Cyanocobalamin | Nutrition and Blood | No data available |
|
Cytacon 35micrograms/5ml syrup
0901020D0BCABAG
|
Cytacon | Cyanocobalamin | Nutrition and Blood | No data available |
|
Cytacon 50microgram tablets
0901020D0BCAAAE
|
Cytacon | Cyanocobalamin | Nutrition and Blood | No data available |
|
Purosure Cyanocobalamin 50microgram tablets
0901020D0BNAAAE
|
Purosure Vitamin B12 | Cyanocobalamin | Nutrition and Blood | No data available |
|
SunVit-Pro Vitamin B12 1000microgram modified-release tab
0901020D0BPABAH
|
SunVit-Pro Vitamin B12 | Cyanocobalamin | Nutrition and Blood | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.